Natesto
Total Payments
$1.5M
Transactions
22,287
Doctors
8,025
Companies
4
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $219.20 | 12 | 12 |
| 2022 | $314,206 | 4,102 | 2,265 |
| 2021 | $543,161 | 3,658 | 2,154 |
| 2020 | $118,379 | 1,994 | 1,257 |
| 2019 | $174,193 | 3,324 | 1,761 |
| 2018 | $200,636 | 5,091 | 2,492 |
| 2017 | $131,688 | 4,106 | 2,191 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $546,727 | 146 | 36.9% |
| Food and Beverage | $365,677 | 21,878 | 24.7% |
| Consulting Fee | $320,399 | 103 | 21.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $209,620 | 45 | 14.1% |
| Travel and Lodging | $35,234 | 101 | 2.4% |
| Honoraria | $4,800 | 12 | 0.3% |
| Education | $26.10 | 2 | 0.0% |
Payments by Type
General
$935,756
22,141 transactions
Research
$546,727
146 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| 24-hour Ambulatory Blood Pressure Monitoring Study in Hypogonadal Men Treated with Natesto Nasal Testosterone Gel | Acerus Pharmaceuticals Corporation | $437,697 | 0 |
| A Comparison of Side Effects in Hypogonadal Men Treated with Natesto versus Testosterone Injections | Acerus Pharmaceuticals Corporation | $63,263 | 0 |
| Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters | Aytu BioScience, Inc | $25,004 | 0 |
| A Comparison of Side Effects in Hypogonadal Men Treated with Natesto versus Testosterone Injections: A Phase IV, Prospective, Randomized, Non-Blinded, Multi-Institutional Study | Acerus Pharmaceuticals Corporation | $20,763 | 0 |
Top Doctors Receiving Payments for Natesto — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Urology | San Antonio, TX | $5,960 | 18 |
| , FNP | Nurse Practitioner | Helotes, TX | $5,959 | 36 |
| , M.D | Endocrinology, Diabetes & Metabolism | Flower Mound, TX | $5,754 | 14 |
| , M.D | Endocrinology, Diabetes & Metabolism | Beaumont, TX | $5,616 | 5 |
| , MD | Endocrinology, Diabetes & Metabolism | Louisville, KY | $5,042 | 7 |
| Basil Kaaki | Physician Assistant | Houston, TX | $4,992 | 3 |
| , MD | Urology | Houston, TX | $4,955 | 26 |
| , M.D | Urology | New York, NY | $4,716 | 13 |
| , M.D | Urology | Brooklyn, NY | $4,680 | 17 |
| , MD | Urology | West Hartford, CT | $4,658 | 7 |
| , MD, FACS | Urology | Purchase, NY | $4,602 | 12 |
| , M.D | Urology | Clifton, NJ | $4,259 | 8 |
| , MD | Family Medicine | Austin, TX | $4,251 | 10 |
| , MD | Urology | Clifton, NJ | $4,199 | 3 |
| , D.O | Family Medicine | Rancho Cucamonga, CA | $4,127 | 27 |
| , MD | Urology | Brooklyn, NY | $3,793 | 16 |
| , MD | Urology | Costa Mesa, CA | $3,500 | 1 |
| , MD | Urology | New York, NY | $3,472 | 12 |
| , MD | Endocrinology, Diabetes & Metabolism | New York, NY | $3,463 | 18 |
| , MD | Urology | New Orleans, LA | $3,266 | 4 |
| , M.D | Internal Medicine | Seattle, WA | $3,138 | 6 |
| , MD | Urology | Boston, MA | $3,063 | 37 |
| , D.O | Specialist | Philadelphia, PA | $2,914 | 56 |
| , MD | Urology | San Diego, CA | $2,497 | 31 |
| , MD | Urology | Millburn, NJ | $2,320 | 18 |
Ad
Manufacturing Companies
- Acerus Pharmaceuticals Corporation $928,664
- Aytu BioScience, Inc $308,810
- Aytu Bioscience, Inc $240,916
- Aytu BioPharma, Inc. $4,093
Product Information
- Type Drug
- Total Payments $1.5M
- Total Doctors 8,025
- Transactions 22,287
About Natesto
Natesto is a drug associated with $1.5M in payments to 8,025 healthcare providers, recorded across 22,287 transactions in the CMS Open Payments database. The primary manufacturer is Acerus Pharmaceuticals Corporation.
Payment data is available from 2017 to 2023. In 2023, $219.20 was paid across 12 transactions to 12 doctors.
The most common payment nature for Natesto is "Unspecified" ($546,727, 36.9% of total).
Natesto is associated with 4 research studies, including "24-hour Ambulatory Blood Pressure Monitoring Study in Hypogonadal Men Treated with Natesto Nasal Testosterone Gel" ($437,697).